Published: July 2025 | Last updated: May 2026
Gender-affirming care saves lives. Hormones, surgery referrals, mental-health support, all of it adds up to real improvements in well-being. But when the visit checklist focuses on transition milestones, sexual health often goes unmentioned. No swab. No fingerstick. No conversation about who you're having sex with or what kinds of contact you're having. For a population that public-health data consistently shows is at elevated STI risk, that silence has consequences.
This article walks through what the gap looks like, what tests actually match your anatomy and behavior, why hormones don't change what you need to screen for, and how to ask for the right care. We also cover when at-home testing makes sense, what to do about PrEP, and how to push back when a provider waves the topic away.
Why Gender-Affirming Care Often Skips Sex
Gender-affirming medicine grew up around a specific set of services: hormone management, mental-health letters, surgery referrals, and follow-up bloodwork for liver and lipid panels. Sexual health was never the starting point. As a result, many hormone-focused clinics never built sexual-history intake into their standard visits.
Add to that the way US medical education siloes sex into separate STI clinics and reproductive-health centers, and you get hormone clinicians who often don't feel trained to ask. Some avoid the topic because they don't want to seem invasive. Others assume hormones automatically change a patient's behavior, or that transition surgery removes the need to test. None of those assumptions hold up.
The result is patients on testosterone or estrogen who have never been asked when they last had sex, with whom, or in what way. The omission gets read as respect; in practice, it's a screening failure. Per the CDC's STI treatment guidelines for transgender and gender-diverse persons, screening should follow behavior and anatomy, not identity labels, and clinicians should normalize asking about sexual practices.
Transgender persons should be assessed for STI- and HIV-related risks based on current anatomy and sexual behaviors.
What Higher Risk Actually Means in the Data
Trans communities, especially transgender women and trans people of color, carry a disproportionate share of STI burden. Reviews of US testing data from gender clinics and STI clinics have repeatedly found bacterial STI positivity rates well above general-population averages, with the highest rates clustering in transgender women, sex workers, and people whose partners are men who have sex with men.
HIV burden in the same populations is also disproportionately high. CDC HIV surveillance data documents a long-standing pattern: trans women, particularly Black and Latina trans women, are diagnosed at rates many times the national average. The reasons aren't biological. They're structural: stigma in clinical settings, employment and housing instability, gaps in insurance, and the way bias deters people from coming back for routine care.
For the patient, that translates to a simple rule of thumb: if you're sexually active and the only doctor you see regularly handles your hormones, your STI screening probably has to start with you bringing it up at the next visit.
Risk depends on behavior and exposure, not gender. Factors that push individual risk higher include multiple partners, condomless sex, partners with unknown status, injection-drug use or hormone injection with shared needles, and history of incarceration or housing instability. Screening cadence and which sites get swabbed should match these factors, not the gender marker on your chart.
Anatomy Decides What to Test, Not Identity
The single most important shift in trans-inclusive STI care is this: tests are matched to the body parts you have and the body parts you use during sex, not to your gender on paper. CDC and UCSF's transgender care guidelines both frame screening this way.
What that looks like in practice:
- A trans man on testosterone who still has a cervix and has receptive front-hole sex needs cervical or vaginal chlamydia and gonorrhea screening, even if his chart says male.
- A trans woman who has receptive oral and anal sex needs throat and rectal swabs, regardless of whether she's had bottom surgery.
- A non-binary person with a penis who has insertive sex needs urethral or urine-based screening; if they also have receptive anal sex, they need a rectal swab too.
- Anyone sharing needles, whether for hormones, drugs, or anything else, needs bloodborne-infection screening: HIV, hepatitis B, hepatitis C.
Body-part-based screening sounds obvious, but it requires the clinician to actually ask what kinds of sex you have. Many don't, which is why patients often have to bring it up first.
How Hormones and Surgery Change Your Screening Plan
Hormones reshape a lot of things. They don't reshape which STIs you can get. A trans woman on estrogen can still acquire HIV, chlamydia, gonorrhea, syphilis, herpes, hepatitis B, hepatitis C, HPV, and trichomoniasis through the same routes anyone else can. A trans man on testosterone can still acquire all of the same infections, and he should continue cervical screening on the timetable his anatomy requires until bottom surgery removes the cervix.
On HPV specifically, the UCSF guidelines are clear: a trans man with a retained cervix should continue Pap smears on the standard cadence (every three years from age 21 to 65 with cytology alone, or every five years with HPV co-testing from age 30), unless a total hysterectomy has removed the cervix. Testosterone does not change that schedule. If a Pap has been deferred because dysphoria makes the exam hard, it is worth asking about smaller speculums, self-collected HPV sampling where offered, or sedation.
What hormones can do is change mucosal tissue. Testosterone tends to thin and dry the vaginal lining over time, which can increase fragility and the chance of microabrasions during sex. For some people this makes condoms, generous lube, or topical estrogen worth discussing with a provider, both for comfort and for infection prevention.
Bottom surgery changes what to swab, not whether to test. After vaginoplasty, the neovagina has its own mucosal lining and can harbor infection; people who have receptive sex with the neovagina still need screening. After phalloplasty or metoidioplasty, the surgical anatomy still includes a urethra, and any retained internal organs (cervix, vagina) still need their original screening as long as they're in place. The UCSF guidelines spell these scenarios out in detail and are worth bringing into a conversation with a provider who hasn't seen them.
Do hormones or transition surgery change which STIs I can get?
No. Hormones don't protect against any STI, and transition surgery doesn't change which infections are possible, only which body parts a clinician should swab. If you have a cervix, you screen the cervix. If you have a neovagina and use it for sex, you screen the neovagina. If you have receptive oral or anal sex, you screen the throat and rectum. Identity follows the chart; testing follows the body.
PrEP Works With HRT, and Most Trans People Aren't Offered It
Pre-exposure prophylaxis (PrEP) is a daily or on-demand medication that substantially reduces the risk of acquiring HIV through sex. Per CDC PrEP guidance, it's safe and effective across populations, including transgender adults on hormone therapy.
Two misconceptions worth correcting:
- PrEP doesn't interfere with hormone levels. Studies in trans women on estrogen have found no clinically significant impact on hormone concentrations when both medications are taken as directed.
- You don't need to be high-risk by some external definition. If you're sexually active and concerned about HIV exposure, PrEP is a reasonable conversation to have with a provider.
Yet uptake remains low in trans populations, especially among transmasculine people and trans women of color. Barriers include providers who don't bring it up, insurance and pharmacy obstacles, and fear of being judged for honest answers about sex. If your gender-affirming clinician hasn't offered PrEP counseling and HIV testing as part of routine care, that's a reasonable thing to ask for, or to seek out at a sexual-health clinic or telehealth PrEP service that integrates the two.
A note on commerce: stdrapidtestkits.com sells the at-home rapid tests linked in the banners below, including the HIV test in this section. Product recommendations on this site are matched to topic fit, not to commercial benefit.
At-Home Testing When Clinics Fall Short
At-home STI tests aren't a replacement for a full sexual-health visit. They are a useful tool when getting that visit feels unsafe, unaffordable, or just exhausting. For trans patients who've cycled through providers who got pronouns wrong or rushed the conversation, an at-home test can be a low-friction way to keep current on screening.
A few things worth knowing about what at-home rapid tests can and can't do:
- Most at-home rapid tests are lateral-flow immunoassays. They give a quick yes or no answer for the specific marker they target. A positive result should be confirmed by a lab test ordered through a clinician.
- Sample type matters. Blood tests for HIV, syphilis, hepatitis B and C, and HSV antibody panels use a fingerstick. Genital swab tests for chlamydia and gonorrhea use a self-collected genital swab.
- Our at-home swab kits for trichomoniasis and HPV are validated for vaginal self-swab only and aren't a fit for someone without a vagina; our chlamydia and gonorrhea swab kits work for either sex of anatomy.
- We do not currently sell pharyngeal (throat) or rectal swab tests. If your sexual practices include those sites, those swabs need to be done in a clinic or via a lab-based mail-in service.
If a rapid result comes back positive, or if symptoms keep going after a negative, book a clinician visit within a week for confirmation testing and treatment.
Scripts for Asking About Sexual Health
It shouldn't fall on you to educate your provider. In practice, it often does. If your gender-affirming clinician doesn't bring up STI testing, opening the conversation usually works better than waiting:
- “I'd like to make sure my STI screening is up to date today. Can we talk about which tests fit my body and how I'm having sex right now?”
- “I have receptive oral and anal sex with men. Do you do throat and rectal swabs here, or do I need a referral?”
- “I still have a cervix. When was my last Pap, and is it time to repeat it?”
- “I'm on testosterone and noticing some vaginal dryness during sex. Could topical estrogen or extra lube reduce my STI risk?”
- “I'd like to talk about PrEP, even if you don't usually bring it up in this clinic. Can you prescribe it or refer me?”
If the response is dismissive or vague, that's information about the clinician, not about whether you need the test. You're allowed to walk out and find a better fit, especially if your area has a community health center with explicit trans-inclusive sexual-health services.
Visits run short and dysphoria can make it hard to remember everything you wanted to ask. Writing your two or three priority questions on your phone or a notecard before the appointment, and handing it to the clinician at the start, sets the agenda without forcing you to perform calm. “These are the things I'd like to cover today” is a complete sentence.
Trauma-Informed Care, Especially Around Sex
Many trans patients come into appointments carrying real history with medical settings: being misgendered, being gawked at, being asked invasive questions that had nothing to do with the visit, being denied care. Sexual-health conversations sit on top of that history. A good clinician handles them with consent and language that follows the patient.
What that looks like:
- Asking what words you use for your body before using their own, and remembering what you say.
- Asking permission before examining genitals or any part of your body, every time.
- Framing screening as something you can opt into, not something done to you. “Would you like to add STI screening to today's visit?” lands differently from “I'm just going to test you for everything.”
- Explaining what each test is, where the swab goes, and what a positive or negative result actually means.
If a clinician routinely skips these steps, that's a signal to look for somewhere else when it's possible. Trans-led clinics, Planned Parenthood affiliates with explicit trans care, and university student-health centers often have better track records than generic primary care.
Equity Gaps That Compound the Problem
The STI care gap doesn't fall evenly across trans people. Black and Latina trans women carry the highest HIV burden in the US. Rural trans patients often have one clinic option that handles hormones but no on-site STI screening. Trans people who are sex workers, undocumented, incarcerated or recently released, or living with disabilities face additional barriers that compound everything above: stigma at intake, transportation, insurance, and prior medical trauma that makes coming back harder.
These aren't identity stories. They're structural ones. A trauma-informed, intersectional approach treats every patient as a whole person, including their sex life, their work, their housing, and their health risks, and offers concrete next steps rather than vague reassurance.
- Black and Latina trans women carry the highest HIV diagnosis rates in CDC surveillance for trans populations, several multiples above the national average.
- Rural trans patients often have one local clinic that handles hormones, with no on-site STI screening and the nearest sexual-health clinic an hour or more away.
- Disabled trans patients and those with histories of medical mistreatment report higher rates of avoiding follow-up care entirely, including for STI symptoms.
If your situation maps to any of these, ask peers about trans-led clinics in your region, and treat at-home testing as a legitimate primary tool, not a fallback.
A Sex-Positive Self-Care Toolkit
You can't always change the system this week. You can pick up a few practical habits that make your sexual health more manageable in the meantime:
- Track your own testing history. Keep a private note with dates, which sites were tested, and the result. It helps you spot screening gaps and saves time at every new clinic.
- Stock supplies that match your sex life. Condoms, internal condoms, dental dams, water- or silicone-based lube, and gloves all reduce STI transmission. Lube specifically matters for anyone with thinning vaginal tissue on testosterone or after vaginoplasty.
- Use your words. Whether you say front hole, T-dick, bottom growth, neovagina, or anything else, you set the language. A clinician who can't follow your lead isn't a long-term fit.
- Build a small team. An affirming primary-care or gender-clinic provider plus a trans-aware sexual-health resource (a Planned Parenthood, a community health center, or a telehealth service) covers most of what you need.
- Use at-home tests as a bridge. They aren't a replacement for clinic care, but they're a reasonable way to keep testing current between visits, especially after new partners or a missed cycle of routine screening.
The simplest place to start: open the notes app on your phone right now and write down the date of your most recent STI test and which sites it covered.
Of the five tools above, the testing-history note is the one that pays off fastest. A single dated line per test, kept where you can read it before any appointment, makes you the most informed person in the room about your own screening status and saves you from having to reconstruct the timeline from memory.
Frequently Asked Questions
- Do hormones change my STI risk?
- No. Estrogen and testosterone don't protect against any STI. Testosterone can thin vaginal tissue over time, which may slightly increase fragility during sex; that's worth talking to your provider about but doesn't change which infections you can get.
- Which tests do I need if I've had bottom surgery?
- Screening matches your current anatomy and sexual practices. After vaginoplasty, the neovagina can carry infection from receptive sex and should be screened when relevant. After phalloplasty or metoidioplasty, any retained internal organs still need their original screening. Throat and rectal swabs follow what kinds of sex you have, not the surgery.
- Are at-home STI tests safe for trans people?
- Yes, with one caveat: pick the kit based on which body parts you have and the kinds of sex you're testing for. HIV, syphilis, and hepatitis tests run off a fingerstick and don't care about anatomy. Genital swabs do. Throat or rectal screening isn't something a home kit can handle, so plan a clinic visit or a lab-based mail-in panel for those sites. Pair anything positive with a confirmatory lab test through a clinician.
- Why don't most gender clinics offer STI testing?
- A combination of factors: clinical training focused on hormones and surgery, the way US medical care siloes sexual health into separate clinics, provider discomfort, and assumptions about who's sexually active. None of these reasons are good ones, but they explain the gap. Advocacy groups and trans-led clinics are pushing the standard of care toward integration.
- Can I take PrEP if I'm on estrogen or testosterone?
- Yes. CDC guidance and trans-specific research both find PrEP safe and effective alongside hormone therapy, with no clinically significant impact on hormone levels when both medications are taken as directed. If your gender-affirming provider doesn't offer it, a sexual-health clinic or a telehealth PrEP service can.
- I'm non-binary. How do I decide which tests to ask for?
- Match tests to anatomy and to what kinds of sex you're having. Receptive oral sex calls for a throat swab. Receptive anal sex calls for a rectal swab. Front-hole or vaginal sex with a cervix calls for cervical or vaginal screening. Penile insertive sex calls for urethral or urine-based screening. A clinician should walk you through this without making you justify your identity.
- Do trans men with a cervix still need Pap smears?
- Yes. Per UCSF guidance, a retained cervix needs a Pap every three years from age 21 to 65 with cytology alone, or every five years from age 30 with HPV co-testing. Testosterone doesn't change that schedule. If dysphoria has kept you from the exam, ask about smaller speculums or self-collected HPV sampling where it's offered.
Sexual Health Is Part of Affirming Care
If your gender-affirming clinic isn't bringing up STI screening, the answer isn't to assume you don't need it. The answer is to ask, to seek out clinicians who integrate sexual health into trans care by default, or to bridge the gap with at-home testing while you're shopping for a better long-term fit. Hormones and surgery referrals are one part of the picture. The rest of your body, including your sex life, deserves the same level of attention.
- U.S. Centers for Disease Control and Prevention. STI Treatment Guidelines: Transgender and Gender Diverse Persons. Anatomy- and behavior-based screening recommendations.
- University of California San Francisco Center of Excellence for Transgender Health. Screening for Sexually Transmitted Infections. Surgical-anatomy-specific screening guidance.
- U.S. Centers for Disease Control and Prevention. Pre-Exposure Prophylaxis (PrEP) for HIV prevention. Safety, eligibility, and effectiveness timelines for daily oral PrEP.
- U.S. Centers for Disease Control and Prevention. HIV surveillance and population data, including transgender reporting and transmission-route statistics.
- World Health Organization. Sexually transmitted infections (STIs) fact sheet. Global incidence, screening principles, and population-level burden.
